Certara, Inc. (CERT)

Certara Inc (CERT) is a company that provides software and scientific consulting services to the biopharmaceutical industry. The company's software is used for drug discovery and development, regulatory submissions, and pharmacovigilance. Certara's consulting services include modeling and simulation, clinical pharmacology, and regulatory affairs. The company was founded in 2008 and is headquartered in Princeton, New Jersey. It went public on the Nasdaq stock exchange in November 2020.